Skip to main content

Cost-effectiveness and budget impact analysis of screening and preventive interventions for cardiovascular disease in Myanmar: an economic modelling study.

Publication ,  Journal Article
Win, ZM; Mao, W; Traill, T; Kyaw, ZL; Paing, PY; Ogbuoji, O; Yamey, G
Published in: The Lancet regional health. Southeast Asia
July 2024

Cardiovascular diseases (CVD) remains a leading cause of mortality in Myanmar. Despite the burden, CVD preventive services receive low government and donor budgets, which has led to poor CVD outcomes.We conducted a cost-effective analysis and a budget impact analysis on CVD prevention strategies recommended by the WHO. A Markov model was used to analyse the cost and quality-adjusted life year (QALY) from healthcare provider and societal perspectives. We calculated transition probabilities from WHO CVD risk data and obtained treatment effects and costs from secondary sources. Subgroup analysis was performed on different sex and age groups. We framed the budget impact analysis from a healthcare provider perspective to assess the affordability of providing CVD preventive care.The most cost-effective strategy from the healthcare provider perspective varied. The combination of screening, primary prevention, and secondary prevention (Sc-PP-SP) (incremental cost-effectiveness ratio [ICER]: US$1574/QALY) is most cost-effective at the three times gross domestic product (GDP) per capita threshold, while at one time the GDP per capita threshold, secondary prevention is the most cost-effective strategy (ICER: US$160/QALY). Sc-PP-SP is the most cost-effective strategy from the societal perspective (ICER: US$647/QALY). Among age groups, intervention at age 45 years appeared to be the most cost-effective option for both men and women. The budget impact revealed the Sc-PP-SP would avert 55,000 acute CVD events and 28,000 CVD-related deaths with a cost of US$157 million for the first year of CVD preventive care.A combination of screening, primary prevention, and secondary prevention is cost-effective to reduce CVD-related deaths in Myanmar. This study provides evidence for the government and development partners to increase investment in and support for CVD prevention. These findings not only provide a basis for efficient resource allocation but also underscore the importance of adopting a total cardiovascular risk approach to CVD prevention, in alignment with global health goals.Pilot grant from Duke Global Health Institute, USA.

Duke Scholars

Published In

The Lancet regional health. Southeast Asia

DOI

EISSN

2772-3682

ISSN

2772-3682

Publication Date

July 2024

Volume

26

Start / End Page

100394
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Win, Z. M., Mao, W., Traill, T., Kyaw, Z. L., Paing, P. Y., Ogbuoji, O., & Yamey, G. (2024). Cost-effectiveness and budget impact analysis of screening and preventive interventions for cardiovascular disease in Myanmar: an economic modelling study. The Lancet Regional Health. Southeast Asia, 26, 100394. https://doi.org/10.1016/j.lansea.2024.100394
Win, Zin Mar, Wenhui Mao, Tom Traill, Zarni Lynn Kyaw, Pyone Yadanar Paing, Osondu Ogbuoji, and Gavin Yamey. “Cost-effectiveness and budget impact analysis of screening and preventive interventions for cardiovascular disease in Myanmar: an economic modelling study.The Lancet Regional Health. Southeast Asia 26 (July 2024): 100394. https://doi.org/10.1016/j.lansea.2024.100394.
Win ZM, Mao W, Traill T, Kyaw ZL, Paing PY, Ogbuoji O, et al. Cost-effectiveness and budget impact analysis of screening and preventive interventions for cardiovascular disease in Myanmar: an economic modelling study. The Lancet regional health Southeast Asia. 2024 Jul;26:100394.
Win, Zin Mar, et al. “Cost-effectiveness and budget impact analysis of screening and preventive interventions for cardiovascular disease in Myanmar: an economic modelling study.The Lancet Regional Health. Southeast Asia, vol. 26, July 2024, p. 100394. Epmc, doi:10.1016/j.lansea.2024.100394.
Win ZM, Mao W, Traill T, Kyaw ZL, Paing PY, Ogbuoji O, Yamey G. Cost-effectiveness and budget impact analysis of screening and preventive interventions for cardiovascular disease in Myanmar: an economic modelling study. The Lancet regional health Southeast Asia. 2024 Jul;26:100394.

Published In

The Lancet regional health. Southeast Asia

DOI

EISSN

2772-3682

ISSN

2772-3682

Publication Date

July 2024

Volume

26

Start / End Page

100394